Search research articles
Contact Us
Filters
Showing results (91-100 of 94) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 94 results.
Paediatric and Perinatal Epidemiology
|
November 29, 2021
The Nutrition in Early Life and Asthma (NELA) birth cohort study: Rationale, design, and methods
Eva Morales, Maria V Alcantara-Lopez, Juan Cabezas-Herrera, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Subsistence transition preceded population turnover in the eastern Colombian Andes
Kendra Sirak, Miguel Delgado, Angélica Triana, et al.
Journal of the Endocrine Society
|
March 9, 2026
Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study
Montserrat Marques-Pamies, Laura Ricou, Joan Gil, et al.
Frontiers in Oncology
|
March 12, 2026
Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: results from the multicenter retrospective observational SACISUR cohort in Southern Spain
Alejandro Falcón-González, Elisenda Llabrés-Valenti, Fernando Henao-Carrasco, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 94) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 94 results.
Paediatric and Perinatal Epidemiology
|
November 29, 2021
The Nutrition in Early Life and Asthma (NELA) birth cohort study: Rationale, design, and methods
Eva Morales, Maria V Alcantara-Lopez, Juan Cabezas-Herrera, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Subsistence transition preceded population turnover in the eastern Colombian Andes
Kendra Sirak, Miguel Delgado, Angélica Triana, et al.
Journal of the Endocrine Society
|
March 9, 2026
Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study
Montserrat Marques-Pamies, Laura Ricou, Joan Gil, et al.
Frontiers in Oncology
|
March 12, 2026
Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: results from the multicenter retrospective observational SACISUR cohort in Southern Spain
Alejandro Falcón-González, Elisenda Llabrés-Valenti, Fernando Henao-Carrasco, et al.
Page
of 10